Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

pDC depletion induced by CD317 blockade drives the antitumor immune response in head and neck squamous cell carcinoma
Leilei Yang, Liang Mao, Hao Wu, et al.
Oral Oncology (2019) Vol. 96, pp. 131-139
Closed Access | Times Cited: 20

Showing 20 citing articles:

LAG-3 as the third checkpoint inhibitor
Vaishali Aggarwal, Creg J. Workman, Dario A.A. Vignali
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1415-1422
Open Access | Times Cited: 160
Opposing Roles of Type I Interferons in Cancer Immunity
Giselle M. Boukhaled, Shane M. Harding, David G. Brooks
Annual Review of Pathology Mechanisms of Disease (2020) Vol. 16, Iss. 1, pp. 167-198
Open Access | Times Cited: 139
Immune Checkpoint Inhibitors in Oral Cavity Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: A Systematic Review
Omar Kujan, Bede van Schaijik, Camile S. Farah
Cancers (2020) Vol. 12, Iss. 7, pp. 1937-1937
Open Access | Times Cited: 67
Tumor microenvironment-related dendritic cell deficiency: a target to enhance tumor immunotherapy
Shan Zhu, Ning Yang, Jing Wu, et al.
Pharmacological Research (2020) Vol. 159, pp. 104980-104980
Closed Access | Times Cited: 55
The Role of Plasmacytoid Dendritic Cells in Cancers
Binhui Zhou, Toby Lawrence, Yinming Liang
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 55
The Role of Immune Modulatory Cytokines in the Tumor Microenvironments of Head and Neck Squamous Cell Carcinomas
Nobuo Kondoh, Masako Mizuno‐Kamiya
Cancers (2022) Vol. 14, Iss. 12, pp. 2884-2884
Open Access | Times Cited: 33
Bone marrow stromal cell antigen 2: Tumor biology, signaling pathway and therapeutic targeting (Review)
Honglian Yu, Qiang Bian, Xin Wang, et al.
Oncology Reports (2024) Vol. 51, Iss. 3
Open Access | Times Cited: 7
Type I conventional dendritic cells and CD8+ T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients
Johanna Kirchner, Ioana Plesca, R Rothe, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma
Matilde Monti, Francesca Consoli, Raffaella Vescovi, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 417-417
Open Access | Times Cited: 33
Early antitumor activity of oral Langerhans cells is compromised by a carcinogen
Yasmin Saba, Itay Aizenbud, Daniela Matanes, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 3
Open Access | Times Cited: 18
Update on lymphocyte-activation gene 3 (LAG-3) in cancers: from biological properties to clinical applications
Lishu Zhao, Hao Wang, Kandi Xu, et al.
Chinese Medical Journal (2022) Vol. 135, Iss. 10, pp. 1203-1212
Open Access | Times Cited: 16
Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer
Enrica Marmonti, Jacqueline Oliva, Cara Haymaker
Cells (2022) Vol. 11, Iss. 19, pp. 3028-3028
Open Access | Times Cited: 15
Hypoxia promotes the tolerogenic phenotype of plasmacytoid dendritic cells in head and neck squamous cell carcinoma
Fan Cui, Jichang Wu, Yilin Shen, et al.
Cancer Medicine (2021) Vol. 11, Iss. 4, pp. 922-930
Open Access | Times Cited: 20
CCR9-CCL25 mediated plasmacytoid dendritic cell homing and contributed the immunosuppressive microenvironment in gastric cancer
Hang Yu, Ying Mei, Yang Dong, et al.
Translational Oncology (2023) Vol. 33, pp. 101682-101682
Open Access | Times Cited: 7
The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC
Vladimír Koucký, Kamila Hladíková, Eliška Táborská, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 9, pp. 2545-2557
Open Access | Times Cited: 16
Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer
Wei Ye, Meiye Li, Ke-Wang Luo
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1788-1788
Open Access | Times Cited: 6
Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity
Leilei Yang, Songya Li, Liuhui Chen, et al.
Cancer Biology and Medicine (2023), pp. 1-20
Open Access | Times Cited: 6
Myeloid-derived suppressor cells in head and neck squamous cell carcinoma
Jing-Yu He, Fang‐Yi Huo, Hongchao Tang, et al.
International review of cell and molecular biology (2023), pp. 33-92
Closed Access | Times Cited: 5
Effector Functions of Dendritic Cells in Cancer: Role of Cytotoxicity and Growth Inhibition
Pratima Chaudhary, Prateek Srivastava, Partha Pratim Manna
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 8
Open Access | Times Cited: 1
Plasmacytoid Dendritic Cells and Cancer
Dipyaman Ganguly
(2022), pp. 133-145
Closed Access
Page 1

Scroll to top